The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?

Pehlivanoglu, Seren; Acar, NUR; Albayrak, Sinan; KARAKAYA, MUHARREM; Ofluoglu, Ali

doi:10.2147/opth.s164960

The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?

Pehlivanoglu S., Acar N., Albayrak S., KARAKAYA M., Ofluoglu A.

Clinical ophthalmology (Auckland, N.Z.), cilt.12, ss.1163-1170, 2018 (Hakemli Dergi)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 12
Basım Tarihi: 2018
Doi Numarası: 10.2147/opth.s164960
Dergi Adı: Clinical ophthalmology (Auckland, N.Z.)
Sayfa Sayıları: ss.1163-1170
Anahtar Kelimeler: lens autofluorescence, diabetes, diabetic retinopathy, HgA1c, fasting plasma glucose, screening, GLYCATION END-PRODUCTS, FOLLOW-UP, MELLITUS, FLUORESCENCE, DIAGNOSIS
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Background: Our purpose was to demonstrate if measuring lens autofluorescence (AF) with a scanning confocal biomicroscope may be used to identify subjects with undiagnosed type II diabetes mellitus (DM), and hence, for it to be used as a marker for the severity of diabetic retinopathy in diabetic patients.